IGC Utang marang Ekuitas IGC Pharma

Logo korporat perusahaan India Globalization Capital (IGC)

IGC Pharma, Inc. (IGC) generates revenue through the development of cannabinoid-based treatments for Alzheimer's disease and the sale of wellness products. The company implements ESG principles by monitoring raw material purity and reducing harmful emissions. Early-stage drug trials are outsourced to third-party contractors to diversify risk. This market valuation chart for the company on the GURU.Markets platform demonstrates a debt-to-equity ratio of 0.19.

IGC: Rasio Total Utang marang Ekuitas IGC Pharma Inc 04.07.2022 - 31.10.2026

IGC Pharma - rincian analitis lan metrik utama (IGC)

- rega saham lan konsensus proyeksi valuasi:
Rega saham India Globalization Capital|IGC - Prakiraan konsensus analis
- data kapitalisasi pasar:
Nilai pasar IGC Pharma|IGC - Nilai Dipunlarasaken Utang lan Kas
- rincian nilai buku perusahaan:
Nilai Buku saben Saham IGC Pharma|IGC - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku igcinc.us|IGC - Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Rasio Total Utang marang Ekuitas IGC Pharma, Inc.|IGC - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal India Globalization Capital|IGC - Gunggung tanggungan utang perusahaan|Utang-utang marang kapitalisasi buku IGC Pharma|IGC - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan IGC Pharma|Likuiditas cepet igcinc.us
- informasi bathi lan kelipatan valuasi:
IGC - Penghasilan resik
Ringkesan analitik perusahaan:IGC Pharma, Inc., IGC
Produk merek IGC Pharma

The specifics of strict government regulation regarding cannabinoid distribution require IGC Pharma, Inc. (IGC) to incur significant logistics security costs, which may impact its financing structure. This financial leverage chart compares the company's total liabilities to its equity, allowing investors to assess the business's reliance on borrowed funds and the risk of cash flow gaps during operational scaling.

Pesaing utama

INDV (Indivior) - Total Utang marang Modal|Total Utang marang Modal Collegium Pharma|Utang marang Ekuitas Cronos (CRON)|CGC (Canopy Growth Corp.) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal HITI (High Tide Inc.)|ACB - Rasio Total Utang marang Ekuitas|ACHV - Utang marang Ekuitas|Utang marang Modal Skye Bioscience Inc.|ANEB (Anebulo) - Rasio Total Utang marang Ekuitas|InterCure - Rasio Kabeh Utang marang Dana Pribadi|NTRB (Nutriband Inc) - Total Utang marang Modal|Nasus Pharma, Ltd. - Utang Agregat marang Ekuitas|Total Utang marang Modal MIRA|Total Utang marang Modal Flora Growth Corp (FLGC)|Utang marang Ekuitas IM Cannabis IMCC|Rasio Kabeh Utang marang Dana Pribadi ADIL|ARTL - Utang marang Ekuitas|Ensysce Biosciences (ENSC) - Rasio Total Utang marang Ekuitas|TTNP: Total Utang marang Modal|GNLN - Koefisien Total Utang marang Modal|INM (InMed Pharma) - Total Utang marang Modal|AKAN - Rasio Utang marang Modal|Total Utang marang Modal ENVB|Rasio Total Utang marang Ekuitas brightgreen.us BGXX|Hempacco Co., Inc. - Rasio Total Utang marang Ekuitas